Tegoprazan And Lansoprazole Effectiveness in Bleeding Peptic Ulcer Treatment
Recruiting now · Not applicable
Conditions studied: Peptic Ulcer Bleeding
In brief
The goal of this clinical trial is to compare the effects of tegoprazan vs lansoprazole in healing bleeding peptic ulcers. It will also teach about the safety of both modalities. The main questions it aims to answer are: How does the effectiveness of Tegoprazan compare with Lansoprazole in two weeks of healing rate bleeding peptic ulcer patients in the Indonesian population? Researchers will compare the drug tegoprazan to lansoprazole with a double-blind randomized control to see their effect on healing bleeding peptic ulcers. Participants will: Take drug tegoprazan 50 mg OD or lansoprazole 30 mg OD every day for 2 weeks Endoscopic examination at the beginning before treatment and after completion of treatment within 2 weeks Record of their adverse effect occurrence
Key facts
- Study ID
- NCT06894992
- Run by
- Mario Steffanus
- People needed
- 162
- Starts
- 2025-05-01
- Expected to finish
- 2025-12-31
- Last updated by the study team
- 2025-05-29
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subjects diagnosed with upper gastrointestinal bleeding caused by peptic ulcer through gastroscopic examination
You may not qualify if…
- Allergic to Tegoprazan or Lansoprazole
- Diagnosed with gastric or duodenal cancer, pregnant
- History of H. pylori infection treatment failure
- Presence of comorbidities such as chronic kidney disease or decompensated liver cirrhosis
- Alcohol consumption
- Undergoing chemotherapy
Where it is running
- Cipto Mangunkusumo National General Hospital — Jakarta, DKI Jakarta, Indonesia (enrolling)
- Atma Jaya Hospital — Jakarta, DKI Jakarta, Indonesia (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.